← Leaderboards
James E. Tisdale
Indiana Univ-Purdue Univ At Indianapolis
$2,409,543
Attributed
$2,409,543
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $502.1K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,409,543 · 4
By mechanism
R01$2,409,137 · 1
M01$406 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Jeffrey E Olgin$8,884,412
- Lang Li$13,579,025
- Barbara Haehner$0
- Paul Dexter$17,242,349
Others in their field
Top investigators on “Ibutilide”
- Dan M Roden · Vanderbilt University Medical Center$11,189,918
- Wouter-Jan Rappel · University Of California, San Diego$1,151,839
- Colleen E Clancy · Weill Medical Coll Of Cornell Univ$1,063,148
- Robert D Harvey · Case Western Reserve University$1,063,148
- Robert J Levy · Children'S Hosp Of Philadelphia$609,448
- Prince Joseph Kannankeril · Vanderbilt University$496,152
Research focus
IbutilideTorsades De PointesArrhythmiaPharmaceutical PreparationsResearch PersonnelSerumPharmacodynamicsHeart RateFluoroquinolonesHigh RiskElectrocardiogramAttenuatedAttenuationBiological MarkersDouble-Blind MethodAntibioticsDrug UsageCardiovascular PharmacologyClinical TrialsAreaCardiac Electrophysiologic TechniquesCross-Over StudiesDoseAntipsychotic Agents
Grant awards (8)
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening$447,561
R01 · FY2024 · HL · contact PI
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening$502,081
R01 · FY2023 · HL · contact PI
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening$489,481
R01 · FY2022 · HL · contact PI
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening$489,481
R01 · FY2021 · HL · contact PI
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening$480,533
R01 · FY2020 · HL · contact PI
MECHANISMS OF INCREASED RISK OF TORSADES DE POINTES ASSOCIATED WITH POTASSIUM$15
M01 · FY2008 · RR · contact PI
MECHANISMS OF INCREASED RISK OF TORSADES DE POINTES ASSOCIATED WITH POTASSIUM$170
M01 · FY2007 · RR · contact PI
MECHANISMS OF INCREASED RISK OF TORSADES DE POINTES ASSOCIATED WITH POTASSIUM$221
M01 · FY2005 · RR